young woman in an smock young woman in an smock
We are the leader
We are a leading regional (CEE and CIS) manufacturer of pharmaceuticals and a leader of the Polish & Kazakhstan pharmaceutical market. We actively operate in Central and Eastern Europe, the Caucasus and Central Asia. We have been trusted by millions of patients, doctors, pharmacists, and business partners for over 85 years. Together with our strategic partners in Poland, Russia, and Kazakhstan, we produce nearly 750 drugs and healthcare solutions across seven production plants and conduct research and development across five centers.
Read more
Women reading book to children Women reading book to children
We care
In everything we do, we keep patients in mind, supporting them in health and treating them in illness. Every day, we support doctors, nurses, and pharmacists in caring for patients. In our activities, we are guided by the motto "People helping people". Corporate social responsibility is an integral part of our daily activities.
Read more
Laboratory worker during tests Laboratory worker during tests
We develop new products
We produce safe and convenient products for patients. We are also developing products in new, advanced areas, including ophthalmology, asthma and injection forms to help an increasing number of patients. We actively engage with the scientific community, by supporting young scientists and disseminating knowledge.
Read more
Athletes Athletes
We are a successful employer
Polpharma is a workplace that motivates you to develop talent and choose your professional path. Our successes in this area have been recognised in the Pomeranian Employer of the Year, the Ideal Employer and the Employer of Health competitions.
Read more

News

See all
01 July 2021

Polpharma invests PLN 300 million in R&D

Company News
LinkedIn Twitter Facebook Messenger Skopiuj link

On June 29, we signed another significant loan agreement with the European Investment Bank. The investment of PLN 300 million will finance our research, development and innovation (RDI) programme until 2023. The investment will strengthen our position by developing the portfolio of new products and will improve patients’ access to modern medicines in several therapeutic areas, including cardiology, diabetes, ophthalmic and respiratory diseases.

 

Read more

Polpharma in Numbers

85
years of history
Since 1935 our has been to help in taking patients achieve a long and healthy life
7500
employees of Polpharma Group and strategic partners
7
manufacturing plants
Together with our strategic partners, we have a network of production plants in Poland, Kazakhstan and Russia. In addition, we work on more patient-friendly drugs at 5 research and development centres.
woman in a bright dress on a white blue background

Acclaimed employer

7500 people employed in the Polpharma Group and partner companies help provide long and healthy lives.
Join us!
woman in a bright dress on a white blue background Join us!

Polpharma on its websites and mobile applications (“Website”) uses cookies and other related technologies (“cookies”). Self-management of cookies is possible by changing the settings in your web browser. If you do not agree to the collection of personal data through cookies, you can change the settings in your web browser or leave the Website.

By using the Website without changing the settings in your web browser, you accept Polpharma’s use of cookies. By accepting the settings in your web browser, you agree to profiling based on the information contained in cookies. Consent may be withdrawn at any time. Withdrawal of consent does not affect the lawfulness of the processing that was carried out on the basis of consent before its withdrawal.

More information can be found in the Cookies Policy.